Droxidopa: Complete Phase III enrollment

Chelsea completed enrollment of 118 patients in a double-blind, U.S and Canadian Phase III (Study 301) trial comparing 6 dosages of oral droxidopa given thrice daily vs. placebo. Patients responding t...